Immune Checkpoint Inhibitor-Chemo Combo Boosts OS in Advanced Endometrial Cancer

(MedPage Today) -- SAN DIEGO -- The addition of an immune checkpoint inhibitor (ICI) to chemotherapy up front improved overall survival (OS) in patients with advanced or recurrent endometrial cancer, regardless of mismatch repair (MMR) status...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news